logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
12/05/2025
According to the Financial Times: OpenAI is in talks with Microsoft to unlock new funds and a potential future IPO.
Latest
2 m ago
Hengguang Corporation: Termination of investment in the construction of a 270,000 ton annual production green electrochemical materials project.
2 m ago
The USD/JPY exchange rate touched 148 upwards, the first time since April 9, rising by 1.81% within the day.
3 m ago
Guangdong: Reduce the financing costs for manufacturing and high-tech enterprises, with a maximum annual interest subsidy amount of 20 million yuan for individual enterprises.
3 m ago
US pharmaceutical stocks fell across the board before the market opened, with Novonordisk falling 5.25%, AbbVie falling 4.12%, AstraZeneca falling 3.8%, Novartis falling 3.7%, and Gilead Sciences falling 3.46%. Trump announced plans to sign an executive order that will immediately lower drug prices by 30%-80%.
3 m ago
Pre-market trading in US pharmaceutical stocks saw a general decline, with Novo Nordisk (NVO.N) down 5.25%, AbbVie (ABBV.N) down 4.12%, AstraZeneca (AZN.O) down 3.8%, Novartis (NVS.N) down 3.7%, and Gilead Sciences (GILD.O) down 3.46%. Trump announced plans to sign an executive order to immediately lower drug prices by 30%-80%.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.